Clinical Guides
Gonorrhoea
A clinically focused guide to site-specific diagnosis, resistance-aware treatment, complication recognition and confidential partner care for gonorrhoea in Indian clinical practice.
MedNext Academy | 14 min read
Gonorrhoea
A clinically focused guide to site-specific diagnosis, resistance-aware treatment, complication recognition and confidential partner care for gonorrhoea in Indian clinical practice.
Summary
Gonorrhoea is a sexually transmitted infection caused by Neisseria gonorrhoeae, a Gram-negative diplococcus with a marked capacity to acquire antimicrobial resistance. Infection may involve the urethra, endocervix, rectum, pharynx or conjunctiva; the infected anatomical site cannot be inferred reliably from symptoms. Urethral discharge and dysuria are often conspicuous in men, whereas endocervical, rectal and pharyngeal infection may be silent. Absence of symptoms therefore does not mean absence of infection, transmission or future harm.
A sexual history should identify every exposed site so that appropriate specimens are collected. A nucleic-acid amplification test, where locally validated, is the usual sensitive diagnostic test, but culture remains essential when treatment failure or resistance is suspected because NAAT does not produce a viable isolate for antimicrobial-susceptibility testing. Co-testing for chlamydia and offering tests for HIV and syphilis are part of integrated care.
Treatment must follow the current NACO guideline, local protocol and available susceptibility information. WHO updated its gonococcal treatment recommendations in 2024 because resistance patterns continue to change; older prescriptions should not be copied forward. Clinical care also includes partner services, avoidance of sexual contact for the advised interval, test-of-cure when indicated, and retesting for reinfection. Pelvic inflammatory disease, epididymo-orchitis, disseminated infection, pregnancy-related risk and neonatal eye disease require distinct assessment. This educational draft has been reviewed by the MedNext Clinical Team and cannot replace a prescriber, microbiologist or local STI service.
How Common Is It?
Gonorrhoea remains a major global STI, but an honest Indian guide should not convert a clinic series or syndromic-surveillance count into a national incidence. Many infections are asymptomatic, diagnostic access is uneven, private-sector treatment may not enter surveillance, and urethral or vaginal discharge syndromes include several pathogens. Stigma and fear of disclosure further reduce testing. Consequently, notified or laboratory-confirmed cases represent only part of the burden, while modelled global estimates cannot state the rate in a particular Indian district or patient group.
Transmission occurs through vaginal, anal or oral sexual contact and perinatally during birth. Infection at the pharynx or rectum is especially liable to be missed if testing is driven only by genital symptoms. People with a new or multiple partners, inconsistent barrier use, a partner with an STI, previous gonorrhoea, or membership of a sexual network with higher background prevalence have increased probability, but risk assessment must be behaviour-based and non-judgmental. Sexual orientation, gender identity, marital status, occupation or appearance is not a diagnosis.
The epidemiological priority is targeted case finding and interruption of transmission: ask about exposure sites, test the correct specimens, treat promptly using current guidance, support partners, and arrange retesting. Recurrent positivity commonly represents reinfection after an untreated partner or a new exposure, although true antimicrobial treatment failure must be considered when exposure has not recurred. Local laboratories and public-health programmes should preserve culture capacity and report susceptibility patterns. Numbers should always state their population, period, case definition and testing method rather than imply false precision.
Risk Factors
Risk is determined principally by exposure to an infected mucosal site. Relevant factors include a new sexual partner, multiple or concurrent partners, a partner recently diagnosed with gonorrhoea or another STI, inconsistent condom or barrier use, previous bacterial STI, and sexual contact within a network where infection is circulating. Oral and anal exposure matter because pharyngeal and rectal infection may be asymptomatic. Ask about the sex of partners and practices only to guide care, with permission and neutral language. Do not use identity labels as shortcuts, and do not assume that a married person or someone without symptoms is unexposed.
Biological and healthcare factors influence complications. Endocervical infection can ascend and cause pelvic inflammatory disease, particularly when diagnosis is delayed. Pregnancy creates implications for the pregnant person, fetus and newborn. A neonate exposed during birth can develop ophthalmia neonatorum. Immunosuppression does not create gonorrhoea without exposure but may complicate the presentation. Complement deficiency and use of complement-inhibiting medicines increase susceptibility to disseminated Neisseria infection and should be sought when bacteraemia or recurrent invasive disease occurs.
Resistance risk deserves a separate history: previous gonorrhoea, antibiotics taken before testing, treatment outside a documented guideline, persistent symptoms, a positive post-treatment test, recent travel, or contact with a person whose isolate had reduced susceptibility. These features do not prove resistance; reinfection and non-gonococcal causes remain common. They do strengthen the indication for specimens from all relevant sites, culture before retreatment where feasible, susceptibility testing and specialist or microbiology input. Safeguarding risk, sexual coercion, trafficking, assault and fear of partner violence must also shape confidential partner-notification planning.
Diagnosis
History
Ask about dysuria, urethral or vaginal discharge, intermenstrual or postcoital bleeding, pelvic pain, dyspareunia, testicular pain or swelling, proctitis symptoms, sore throat, conjunctival discharge, fever, rash and joint or tendon pain. Establish onset, prior antibiotics and pregnancy possibility. With consent, take a confidential history of vaginal, oral and anal exposures, condom use, partners, prior STIs, HIV status and prevention needs. Clarify allergy phenotype and safeguarding concerns. A site not discussed may become a site not tested.
Examination
First assess systemic illness. Examine only what is clinically necessary and consented, using a chaperone according to policy. Look for urethral or cervical discharge, pelvic or cervical-motion tenderness, epididymal or testicular swelling, proctitis, conjunctivitis, pustular or petechial lesions, tenosynovitis and a hot swollen joint. Pelvic pain needs pregnancy-aware assessment; sudden severe scrotal pain requires immediate consideration of torsion. A normal examination does not exclude mucosal infection.
Investigations
Collect NAAT specimens from every exposed site using assays and specimen types validated by the local laboratory: commonly first-void urine or a genital swab plus rectal or pharyngeal swabs when indicated. Follow local instructions because platform approvals differ. Obtain culture before treatment when failure, resistance, complicated infection or legal/safeguarding evidence is a concern, and arrange susceptibility testing on isolates. A Gram-stained urethral smear showing intracellular Gram-negative diplococci can support an immediate diagnosis in symptomatic men, but a negative smear and smears from other sites are not reliable exclusion tests. Test for chlamydia and offer HIV and syphilis testing. Pregnancy testing, blood cultures, joint aspiration or other investigations follow the syndrome.
Differential Diagnosis
Urethral discharge or dysuria may result from chlamydia, Mycoplasma genitalium, Trichomonas vaginalis, urinary infection, balanitis, prostatitis or non-infective urethral irritation. Cervicitis can be chlamydial, trichomonal, herpetic or non-specific; vaginal discharge more often arises from vaginosis, candidiasis or trichomoniasis than from gonorrhoea alone. A positive gonococcal test does not exclude a second pathogen. Conversely, empiric syndromic treatment should not be mistaken for laboratory confirmation, and persistent symptoms after treatment require reconsideration rather than repeated blind antibiotic courses.
Pelvic pain demands exclusion of ectopic pregnancy, pelvic inflammatory disease with or without tubo-ovarian abscess, appendicitis, ovarian torsion, endometriosis and urinary disease. Acute scrotal pain includes torsion, epididymitis from other organisms, incarcerated hernia and trauma. Rectal pain or discharge may reflect chlamydial proctitis including lymphogranuloma venereum, herpes, syphilis, inflammatory bowel disease or another enteric infection. Pharyngitis is usually unrelated to gonorrhoea, so test according to exposure instead of diagnosing by throat appearance. Purulent conjunctivitis also has bacterial, chlamydial and chemical alternatives but gonococcal disease threatens the cornea.
Disseminated gonococcal infection can present as a dermatitis-tenosynovitis-polyarthralgia syndrome or purulent monoarthritis. Its differential includes septic arthritis from another bacterium, crystal arthritis, reactive arthritis, viral arthritis, infective endocarditis and meningococcal infection. Synovial crystals do not exclude septic arthritis. Obtain blood, mucosal and joint samples as appropriate before antimicrobials when this does not delay emergency care. A negative mucosal NAAT from one site cannot exclude infection at another exposed site or explain all systemic findings.
Management
Provide same-day, resistance-aware treatment when gonorrhoea is confirmed or strongly suspected and delay would risk loss to follow-up or complications. Select the regimen from the current NACO technical guideline and local protocol; WHO's 2024 update supports a ceftriaxone-centred approach but requires adaptation to national susceptibility, medicine availability and individual factors. Determine whether chlamydia has been excluded, document pregnancy, weight where dosing depends on it, renal and hepatic disease, and the nature of any beta-lactam allergy. Do not substitute an older fluoroquinolone, oral cephalosporin or macrolide regimen merely because it is convenient.
Management extends beyond the injection or tablet. Explain the sites infected, possible silent infection, adherence, adverse effects and the need to avoid sexual contact until the guideline-defined interval has passed, symptoms have resolved and partners have been managed. Offer chlamydia, HIV and syphilis testing, hepatitis prevention and vaccination review where appropriate. A person testing HIV negative should receive an individual prevention assessment, including referral for HIV PrEP when clinically indicated and available; a new gonorrhoea diagnosis is an opportunity for prevention, not a moral judgment.
Arrange test-of-cure according to infection site, regimen, pregnancy, symptoms and local guidance. Pharyngeal infection, non-standard therapy and suspected failure warrant particular attention. Retest after treatment to detect reinfection even when a test-of-cure was negative; these answer different questions. Partners need confidential notification, evaluation, testing and treatment within the applicable look-back period. PID, epididymo-orchitis, conjunctivitis or disseminated disease follows a complication-specific pathway and may require admission, longer therapy, drainage or specialist care. Review persistent symptoms with culture and susceptibility testing rather than repeated empiricism.
Prescribing Information
Gonococcal prescribing is unusually sensitive to changing resistance. Verify the current national or state regimen at the time of care and record its version. WHO's 2024 guideline and NACO's 2024 technical guideline are stronger references than an old handbook, but neither removes the need to check local stock, product formulation, contraindications and susceptibility signals. Ceftriaxone is parenteral; correct reconstitution, route, dose, observation and sharps safety matter. Confirm the patient's weight if the applicable guideline uses a weight threshold. If chlamydia has not been excluded, use the current recommended additional coverage, modified for pregnancy or contraindications.
Clarify a reported penicillin or cephalosporin allergy: name the drug, timing, symptoms, treatment required and subsequent beta-lactam tolerance. Gastrointestinal intolerance is not anaphylaxis, while immediate urticaria, bronchospasm, hypotension or a severe cutaneous reaction materially changes decisions. Do not improvise an inferior alternative for a person with severe allergy; obtain sexual-health, infectious-disease or microbiology advice, particularly for pharyngeal, pregnant or complicated infection. Check interactions and pregnancy safety for every companion drug.
For suspected treatment failure, obtain culture from all relevant sites before retreatment when the patient is stable, request quantitative susceptibility testing where available, and distinguish reinfection from failure through an exposure and partner history. Preserve and refer isolates through the local public-health mechanism. A positive NAAT soon after treatment can reflect residual nucleic acid, so timing and confirmatory culture matter. Persistent symptoms also require testing for other pathogens. Document medicine, dose, route, batch or administration record when available, time given, samples collected, counselling, partner plan, test-of-cure plan and retesting date. Antimicrobial stewardship here means effective first treatment plus surveillance, not undertreatment.
When to Refer
Refer immediately to emergency-capable care for sepsis, haemodynamic instability, meningism, a rapidly destructive purulent conjunctivitis, severe pelvic pain with pregnancy possibility, acute testicular pain in which torsion is not excluded, or a hot swollen joint with systemic illness. Suspected disseminated gonococcal infection generally needs hospital assessment, blood and site cultures, joint evaluation and infectious-disease or microbiology input. Purulent arthritis may need orthopaedic drainage. Corneal pain, photophobia, reduced vision or a hyperacute purulent discharge needs urgent ophthalmology because perforation and visual loss can occur.
Urgent gynaecology assessment is appropriate for pelvic inflammatory disease with severe illness, pregnancy, suspected ectopic pregnancy or tubo-ovarian abscess, inability to tolerate outpatient therapy, or non-response. Acute epididymo-orchitis with severe pain, abscess concern or uncertain diagnosis requires urological assessment; torsion is a time-critical surgical diagnosis. Pregnant patients need obstetric coordination and a treatment plan suitable for pregnancy. A neonate with eye discharge, eyelid swelling, sepsis signs or maternal gonorrhoea exposure requires same-day neonatal and paediatric review rather than routine outpatient drops.
Refer to a designated STI service, infectious-disease clinician or clinical microbiologist for suspected resistance, positive test-of-cure, persistent symptoms without re-exposure, severe cephalosporin allergy, pharyngeal infection with limited options, or inability to obtain recommended culture locally. HIV services can provide confirmation, treatment linkage, post-exposure assessment when relevant and PrEP evaluation. Sexual-health referral should remain confidential and non-stigmatising. Safeguarding, assault, coercion or partner-violence risk needs a trained pathway; partner notification must not expose the patient to harm.
Red Flags
Red flags indicate either a complication, an alternative emergency or resistant infection. Fever with hypotension, confusion, rigors, diffuse rash, severe migratory joint pain, tenosynovitis or a swollen joint raises disseminated infection or sepsis. A hot joint must be aspirated and managed as possible septic arthritis; do not label it reactive arthritis without microbiological assessment. Headache with neck stiffness, focal neurology, a new murmur or respiratory compromise broadens concern to meningitis, endocarditis or another invasive process.
Lower abdominal pain with syncope, shoulder-tip pain, bleeding or a positive pregnancy test is an ectopic-pregnancy emergency until proven otherwise. Guarding, persistent vomiting, high fever or an adnexal mass suggests severe PID, abscess or a surgical differential. Sudden testicular pain, a high-riding testis or absent cremasteric reflex requires immediate torsion assessment; an STI history does not make torsion safe to ignore. In pregnancy, fever, abdominal pain, reduced fetal wellbeing or labour symptoms require obstetric escalation.
Hyperacute conjunctival discharge with pain, photophobia, corneal haze or reduced vision threatens sight, particularly in a neonate. Treatment failure is suspected when symptoms persist despite documented recommended therapy and no sexual re-exposure, or when an appropriately timed test remains positive. Obtain culture and susceptibility rather than prescribing successive empirical agents. Severe drug allergy, extensive blistering rash, jaundice, collapse or breathing difficulty after medication is also an emergency. Finally, sexual assault, inability to consent, child sexual abuse, coercion or credible threat from a partner demands private safeguarding action under current law and policy.
Indian Clinical Context
NACO's 2024 National Technical Guidelines on STI and RTI are the primary Indian programmatic reference. They combine syndromic management with improved laboratory diagnosis and referral across different levels of care. Where same-day molecular testing or culture is unavailable, prompt syndromic treatment may be necessary; however, this should not erase the diagnosis problem. Record the syndrome, specimens, regimen, referral and follow-up, and obtain site-specific testing whenever accessible. A foreign regimen should not displace NACO policy without a documented specialist rationale.
Antimicrobial resistance makes laboratory capacity a clinical safety issue. NAAT expands sensitive detection but cannot supply phenotypic susceptibility. Facilities that treat gonorrhoea need a pathway for culture and isolate referral when treatment fails. Antibiotics taken from a pharmacy before sampling may suppress culture without curing infection; ask explicitly and notify the laboratory. Do not assume national susceptibility from a single tertiary-centre study. Local cumulative data require denominator, sampling method, population and time period before they guide therapy.
Access and stigma shape outcomes. Provide a private room, obtain consent for examination and specimens, use the patient's terms for partners and anatomy, and explain confidentiality plus its legal limits. Avoid moralising about marital status, number of partners, sexual orientation, gender identity or HIV. Partner services should be voluntary, safety-assessed and supported through available NACO-linked STI services. Cost, travel and laboratory delays require a realistic follow-up plan rather than instructions the patient cannot complete.
Integrate HIV testing and prevention, syphilis testing, contraception and pregnancy care without making them conditions for treatment. In neonates and pregnancy, coordinate maternity and paediatric pathways. The guide does not claim a precise Indian prevalence or universal availability of NAAT, culture, PrEP or specialist care; clinicians should map their actual district pathway before an emergency occurs.
NMC Competency Mapping
Gonorrhoea integrates microbiology, pharmacology, dermatology and venereology, obstetrics and gynaecology, paediatrics, internal medicine, community medicine and professional communication. The current NMC CBME curriculum should be used to assign the institution's exact competency codes; this guide does not invent a condition-specific code. At the Know level, a learner should describe Neisseria gonorrhoeae, anatomical sites of infection, transmission, antimicrobial resistance, complications and prevention. They should recognize why asymptomatic infection remains epidemiologically important.
At the Know How level, the learner should construct a site-specific testing plan from the sexual history, explain why NAAT and culture have different roles, distinguish test-of-cure from later retesting, and interpret persistent symptoms in terms of reinfection, resistance or another diagnosis. They should compare uncomplicated mucosal disease with PID, epididymo-orchitis, conjunctivitis and disseminated infection, and identify how pregnancy or neonatal exposure changes urgency. Safe prescribing includes checking the current NACO regimen, allergy, pregnancy, interactions and documented administration.
At the Show How level, assessment should include obtaining consent for a confidential sexual history, explaining genital and extragenital sampling, counselling about treatment and temporary sexual abstinence, offering HIV and syphilis testing, and discussing partner services without blame. A learner should be able to prepare a microbiology request for culture and susceptibility and a structured urgent referral. At the Perform level, examination, specimen collection, treatment and notification occur only under appropriate supervision and local policy.
Professional outcomes include confidentiality, trauma-informed care, non-discrimination, antimicrobial stewardship, accurate documentation and safeguarding. Useful assessments are an OSCE on discharge with pharyngeal exposure, a viva on positive post-treatment NAAT, and a case discussion involving pregnancy or a swollen joint.
Key Exam Pearls for NEET PG
1. Neisseria gonorrhoeae is a Gram-negative diplococcus that infects columnar epithelium. Urethral disease may be overt, but endocervical, rectal and pharyngeal infection can be asymptomatic; test exposed sites rather than relying on symptoms.
2. NAAT is generally more sensitive for mucosal infection and supports multi-site testing, whereas culture supplies a viable isolate for antimicrobial-susceptibility testing. Suspected treatment failure requires culture, preferably alongside NAAT, before further antibiotics when clinically safe.
3. A Gram stain showing intracellular Gram-negative diplococci in urethral polymorphonuclear cells can be diagnostic in a symptomatic man. A negative urethral smear does not exclude disease, and smear performance is inadequate at pharyngeal, rectal and endocervical sites.
4. Complications include pelvic inflammatory disease, infertility and ectopic pregnancy risk; epididymo-orchitis; disseminated dermatitis-tenosynovitis-polyarthralgia or purulent arthritis; adult conjunctivitis; and ophthalmia neonatorum. Acute scrotal torsion and ectopic pregnancy remain emergencies in the differential.
5. Use the current NACO regimen and resistance context. WHO updated treatment advice in 2024; avoid memorising an obsolete fluoroquinolone or convenient oral regimen. Treatment failure and reinfection are different, and exposure history plus culture helps separate them.
6. Test-of-cure verifies eradication in selected situations, especially pharyngeal disease or suspected failure; later retesting detects reinfection. Partner evaluation and treatment are core management. Offer testing for chlamydia, syphilis and HIV, and assess HIV PrEP eligibility when HIV testing is negative.
7. For every viva answer, state the infected site, specimen, diagnostic method, resistance plan, complication screen, partner plan and follow-up. Avoid stigmatising language and protect confidentiality.
Frequently Asked Questions
Why are both NAAT and culture used when gonorrhoea treatment may have failed?
NAAT is sensitive and can identify infection from appropriate genital and extragenital specimens, but it does not provide a live organism for phenotypic susceptibility testing. Culture can establish whether an isolate remains viable and which antimicrobials may work. In suspected failure, clinicians should collect both from relevant sites before retreatment when the patient is stable, while also assessing re-exposure and other causes of symptoms.
Does everyone with treated gonorrhoea need the same test-of-cure plan?
No. The plan depends on the anatomical site, regimen used, symptoms, pregnancy and current local guidance. Pharyngeal infection and suspected treatment failure warrant particular attention because eradication can be more difficult and resistance surveillance matters. A later retest for reinfection is still needed when recommended even after a negative test-of-cure, because the two tests answer different clinical questions.
What should happen to the sexual partners of a person diagnosed with gonorrhoea?
Partners within the guideline-defined look-back period should be confidentially notified and offered evaluation, site-appropriate testing and treatment. The exact approach must follow Indian law and local NACO-linked services. Partner work should include safety assessment, especially where disclosure could trigger violence or coercion. Both patient and partners should avoid sexual contact for the advised interval and until treatment requirements are met.
When should disseminated gonococcal infection be suspected rather than uncomplicated mucosal infection?
Suspect dissemination with fever, pustular or petechial skin lesions, migratory polyarthralgia, tenosynovitis or an acutely inflamed joint, especially when mucosal symptoms are absent. This requires urgent hospital assessment, cultures from blood and relevant mucosal or joint sites, and specialist treatment. A hot joint also needs evaluation for other bacterial septic arthritis and crystals do not safely exclude concurrent infection.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic